Accuracy of Community Diagnosis of Idiopathic Interstitial Pneumonias Referred to an Academic Medical Center. A Single Center Experience

CHEST Journal ◽  
2015 ◽  
Vol 148 (4) ◽  
pp. 414A
Author(s):  
Jean Paul Higuero ◽  
James Ravenel ◽  
Timothy Whelan ◽  
John Huggins
Keyword(s):  
Medical Center ◽  
Academic Medical Center ◽  
Single Center ◽  
Idiopathic Interstitial Pneumonias ◽  
Single Center Experience ◽  
Academic Medical ◽  
Community Diagnosis

scholarly journals Automatic ID Consultation for Inpatients With COVID-19: Point, Counterpoint, and a Single-Center Experience

2020 ◽  
Vol 7 (10) ◽  
Author(s):  
Cynthia T Nguyen ◽  
Gregory Olson ◽  
Mai T Pho ◽  
Alison K Lew ◽  
David Pitrak ◽  
...  
Keyword(s):  
Medical Center ◽  
Academic Medical Center ◽  
Single Center Experience ◽  
Academic Medical ◽  
Clinician Satisfaction ◽  
Potential Benefits ◽  
Infectious Diseases Consultation ◽  
The Impact

Abstract There are many unknowns with regard to COVID-19 clinical management, including the role of Infectious Diseases Consultation (IDC). As hospitalizations for COVID-19 continue, hospitals are assessing how to optimally and efficiently manage COVID-19 inpatients. Typically, primary teams must determine when IDC is appropriate, and ID clinicians provide consultation upon request of the primary team. IDC has been shown to be beneficial for many conditions; however, the impact of IDC for COVID-19 is unknown. Herein, we discuss the potential benefits and pitfalls of automatic IDC for COVID-19 inpatients. Important considerations include the quality of care provided, allocation and optimization of resources, and clinician satisfaction. Finally, we describe how automatic IDC changed throughout the COVID-19 pandemic at a single academic medical center.

A single-center cost analysis assessing a change in vasopressin formulation

2021 ◽  
Author(s):  
Courtney E Kelly ◽  
Christopher Miller ◽  
William Darko ◽  
Greg Cwikla ◽  
Bryan Mogle ◽  
...  
Keyword(s):  
Medical Center ◽  
Academic Medical Center ◽  
Cost Savings ◽  
Single Center ◽  
Cost Estimates ◽  
Time Period ◽  
Academic Medical ◽  
Formulation Change ◽  
The Impact ◽  
Pharmacy Leaders

Abstract Purpose Cost savings achieved at an academic medical center by reformulating the institution’s standard vasopressin infusions to reduce waste are described. Summary After a retrospective review of vasopressin utilization over a 4-month period revealed that only approximately 40% of dispensed vasopressin units were actually administered to patients, pharmacy leaders determined that the institution’s standard vasopressin concentration for continuous infusions (100 units in 100 mL of sodium chloride 0.9% injection) was resulting in substantial waste, as many infusion preparations were not needed within the 18- to 24-hour expiration window. A concentration of 20 units/100 mL was adopted as the new standard formulation for vasopressin continuous infusions, with use of alternative concentrations allowed on a restricted basis. A pre-post study to assess the impact of the formulation change indicated a 38.7% decrease in vasopressin utilization (from 21,900 to 8,480 units) relative to utilization in a retrospective sample of patients who received vasopressin infusions prior to the formulation change. This reduced utilization equated to a cost decrease of $55,656.20 (as calculated on the basis of 2017 cost estimates) or $77,214.23 (as calculated on the basis of 2019 cost estimates) for the time period collected. It was estimated that the new formulations could yield annual cost savings ranging from $222,625 to $308,857. Conclusion To our knowledge, this is the first description of cost savings following a change in formulation of vasopressin for continuous infusions. Other institutions could consider employing a similar approach in addition to the previously reported cost-saving interventions, such as lower vasopressin starting doses and vasopressin restriction policies.

Safety of Intravenous Push Ertapenem Compared to Intravenous Piggyback at a Tertiary Academic Medical Center

2021 ◽  
pp. 089719002110383
Author(s):  
Michael J. Corrado ◽  
Andrew Riselli ◽  
Kevin C. McLaughlin ◽  
Paul M. Szumita ◽  
Kevin E. Anger
Keyword(s):  
Medical Center ◽  
Academic Medical Center ◽  
Healthcare Systems ◽  
Institutional Review Board ◽  
P Value ◽  
Single Center ◽  
Infusion Site ◽  
Patients Âgés ◽  
Institutional Review ◽  
Academic Medical

Background: Recent shortages of intravenous (IV) fluids have resulted in healthcare systems converting administration of many medications from IV piggyback (IVPB) to IV push (IVP). Administering medications via IVP presents numerous advantages; however, IV site reactions such as phlebitis and infiltration may occur. Objective: The objective of this analysis is to evaluate the infusion site safety of ertapenem given as peripheral IVP compared to IVPB in adult patients. Methods: This was an institutional review board–approved, single-center, retrospective study. Patients, ages 18 or older, receiving IV ertapenem were identified. The major endpoints analyzed were IV site reactions including phlebitis and infiltration. The Naranjo Nomogram was utilized to assess the causality of the reactions to determine the likelihood of whether the event was caused by the medication itself or other factors. Results: To date, 283 administrations (92 patients) in the IVP group and 319 administrations (82 patients) in the IVPB group were analyzed. There were 13 IV site reactions compared to 8 in the IVP vs IVPB group, respectively ( P-value = 0.16). Ten of the events in the IVP group were deemed “possible” and 2 deemed “doubtful,” while the remaining event was considered “probable” per the Naranjo Nomogram. Of the events in the IVPB group, all 8 were found to be “possible.” Conclusion: The administration of IVP ertapenem showed comparable rates of infusion site reactions compared to IVPB. Implementation of IVP ertapenem appears to be associated with infusion site safety similar to IVPB and should be considered safe to administer.

scholarly journals The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey

2018 ◽  
Vol 54 (3) ◽  
pp. 175-179
Author(s):  
Bryan T. Mogle ◽  
Robert W. Seabury ◽  
Zachary Jones ◽  
Christopher D. Miller ◽  
Jeffrey M. Steele
Keyword(s):  
Infectious Diseases ◽  
Medical Center ◽  
Academic Medical Center ◽  
The United States ◽  
Prescribing Patterns ◽  
Negative Consequences ◽  
Local Resistance ◽  
Single Center ◽  
Academic Medical ◽  
Resistance Rates

Purpose: The United States has seen an increased consumption of carbapenem antibiotics in recent years. The increased utilization of these agents has potential negative consequences, including the increasing incidence of carbapenem-resistant Enterobacteriaceae. Reasons for the rise in carbapenem use among providers in acute care hospitals are not well elucidated in literature. The objectives of this study were to identify factors that influence empiric carbapenem use among providers in a single academic medical center, and to assess therapeutic knowledge pertaining to carbapenem use. Methods: A cross-sectional, single-center, 9-item electronic research survey was developed independently and validated by an infectious diseases pharmacist and infectious diseases physician. The survey was distributed to email accounts of providers at a single academic medical center. Demographic data, factors affecting carbapenem prescription, and baseline therapeutic knowledge were assessed. Results: Ninety-five of 416 providers responded to the survey (response rate of 22.8%). Respondents were well distributed across all levels of training with primary roles in internal medicine and surgery. The most important factors influencing empiric carbapenem use were suspected pathogens at the site of infection, drug allergies, history of multidrug resistant organisms, severity of illness, type of infection, and local resistance rates. A recommendation from a pharmacist was selected as the most likely factor for deterring carbapenem use. Misconceptions pertaining to penicillin drug allergy and beta-lactam cross reactivity, knowledge of local resistance rates according to the institutional antibiogram, and comparative efficacy data for carbapenems were apparent across all levels of training. Conclusions: Provider misconceptions regarding several factors appear to contribute to unnecessary use of carbapenems. An opportunity exists for hospital pharmacists to improve the prescribing patterns of carbapenems by correcting provider misconceptions through education.

Gender differences in career progress and satisfaction in an academic medical center

2002 ◽  
Vol 2 (3) ◽  
pp. 95-104 ◽  
Author(s):  
JoAnn Manson ◽  
Beverly Rockhill ◽  
Margery Resnick ◽  
Eleanor Shore ◽  
Carol Nadelson ◽  
...  
Keyword(s):  
Gender Differences ◽  
Medical Center ◽  
Academic Medical Center ◽  
Academic Medical ◽  
Career Progress
Sign in / Sign up

Export Citation Format

Share Document